Cleared Traditional

Definium Pace Select (K231892) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K231892 · Ge Hualun Medical Systems Co. , Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
76d
Days
Class 2
Risk

K231892 is an FDA 510(k) clearance for the Definium Pace Select. Classified as System, X-ray, Stationary (product code KPR), Class II - Special Controls.

Submitted by Ge Hualun Medical Systems Co. , Ltd. (Beijing, CN). The FDA issued a Cleared decision on September 12, 2023 after a review of 76 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ge Hualun Medical Systems Co. , Ltd. devices

Submission Details

510(k) Number K231892 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2023
Decision Date September 12, 2023
Days to Decision 76 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 107d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPR System, X-ray, Stationary
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KPR System, X-ray, Stationary

All 117
Devices cleared under the same product code (KPR) and FDA review panel - the closest regulatory comparables to K231892.
PodSKAN HF Diagnostic X-ray System
K231761 · Skanray Technologies Limited · Oct 2023
AcuityUDR
K231995 · Radmedix, LLC · Oct 2023
GXR-ES/ECS Diagnostic X-Ray System, (Models GXR-ES series, GXR-ECS series)
K232178 · DRGEM Corporation · Sep 2023
DMX
K223550 · Del Medical, Inc. · Apr 2023
Jumong General
K230241 · Sg Healthcare Co, Ltd. · Feb 2023
DRX - Compass
K223842 · Carestream Health, Inc. · Jan 2023